Skip to main content
Loading

VerImmune Inc

Tuesday, February 27, 2024
Uris
Platform for Therapeutics
VerImmune Inc is developing a highly innovative Virus-inspired Particle (ViP™) platform technology that has the potential to treat multiple diseases, with an initial focus on Oncology.
Speakers
Joshua wang, Founder/CEO - Washington DC

State

DC

Country

United States

Website

http://www.verimmune.com

CEO/Top Company Official

Joshua Wang

Lead Product in Development

VERI-101

Development Phase of Primary Product

Pre-Clinical

Number Of Unlicensed Products

Multiple opportunities for co-discovery
Testimonials

Double Helix


 

Supporting Bank Sponsor


 

Premier Sponsors

Conference Sponsors


 

Media Partner


 

Sign up for updates

Stay up-to-date on the BIO CEO and Investor Conference via email.

SIGN UP